Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Other Non-Current Assets (2019 - 2025)

Outset Medical (OM) has disclosed Other Non-Current Assets for 7 consecutive years, with $538000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets fell 83.84% to $538000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $538000.0, a 83.84% decrease, with the full-year FY2024 number at $2.2 million, down 96.98% from a year prior.
  • Other Non-Current Assets was $538000.0 for Q3 2025 at Outset Medical, down from $560000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $71.8 million in Q4 2023 to a low of $538000.0 in Q3 2025.
  • A 5-year average of $20.1 million and a median of $18.3 million in 2021 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 4383.31% in 2021, then crashed 97.7% in 2025.
  • Outset Medical's Other Non-Current Assets stood at $33.3 million in 2021, then plummeted by 90.06% to $3.3 million in 2022, then soared by 2069.68% to $71.8 million in 2023, then plummeted by 96.98% to $2.2 million in 2024, then tumbled by 75.23% to $538000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Other Non-Current Assets are $538000.0 (Q3 2025), $560000.0 (Q2 2025), and $818000.0 (Q1 2025).